Evaluating the Efficacy of the Sub-psoas Fascial Plane Block for Post-operative Analgesia Following Hemiarthroplasty
NCT ID: NCT06419153
Last Updated: 2024-05-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
80 participants
OBSERVATIONAL
2024-05-13
2024-11-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Ultrasound Guided Fascia Iliaca Block for Pain Control After Elective Hip Replacement Surgery
NCT02108847
Effectiveness of Fascia Iliaca Nerve Block for Post Hip Arthroscopy
NCT02717728
Optimal Positioning of Local Anaesthetic in Femoral Nerve Block Prior to Hip Surgery
NCT01527812
Prospective Comparative Study Between Ultrasound-guided Quadratus Lumborum Block Versus Fascia Iliaca Compartment Block for Postoperative Pain and Cognitive Dysfunction Management in Patient Undergoing Hip Surgery
NCT06407544
USFIB at the Inguinal Ligament for Total Hip Arthroplasty
NCT01911949
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Hip fracture surgery is one of the commonest orthopaedic operations performed in the Republic of Ireland, and is associated with significant patient morbidity, mortality and health care costs. The National Irish Hip Fracture Report recorded 1,950 hip fractures in 2013, 71% were female and the highest proportions were in the 80-89 age group. It has been estimated that the overall prevalence of hip fractures is projected to increase in line with increasing elderly population and projected demographic changes.
Early remobilization has become a key integral component of the optimal post-surgical management of hip fractures. Based on the National Institute for Health and Care Excellence (NICE) guidance, the National Hip Fracture UK Database has adopted patient remobilisation on the day of or day after surgery as a key performance indicator. Early mobilisation has been shown to reduce the risk of in-hospital mortality following hip fracture and to increase the likelihood of discharge from hospital. In 2018, 20% of patients failed to achieve the early remobilisation target, due to pain and/or hypotension, factors which might have been anticipated by clear perioperative protocols and closer working between surgery and anaesthetic colleagues.
Current AAGBI guidelines describe core principles of the peri-operative management of people with hip fracture, with one of their aims recommending a peripheral nerve block immediately prior to operative fixation of a hip fracture (in the Emergency Department and at the time of surgery, provided six hours have passed between blocks). There are two peripheral nerve blocks commonly used in the perioperative setting of hip fracture repair, namely femoral or fascia iliaca block. Both techniques have been proven to be safe and efficacious, however, these peripheral nerve blocks have been associated with some residual muscle weakness and increased falls risk which further hampens the ability of a patient to remobilize post-operatively. There is a clinical need to establish a safe, reliable regional anaesthetic technique that will still offer long-acting opioid sparing analgesia, yet minimise the associated motor blockade in order to improve and facilitate remobilization. By also potentially interrupting the sympathetically mediated pain in the lower limb following hip surgery through the blockade of this lumbar sympathetic plexus, it may provide an avenue to produce significant analgesia without causing somatic sensory deficits (e.g. residual motor weakness), thereby facilitating early remobilisation and enhanced recovery. This is not a new technique, rather it is a new approach to a very well established and utilized technique (the psoas compartment block) which has been shown to be very effective, this approach is expected to be as efficacious and potentially safer than previous approaches as it avoids the nerve roots. In terms of the side effect profile of this novel approach to the PCB - there are no new expected side effects above the standard previously explained effects that can occur with any regional technique (for example, haematoma/ LAST / Neuropraxia). This approach would theoretically be associated with a lower side effect profile than previous landmark or current ultrasound-guided PCB technique as it avoids the risk profile of traversing the psoas muscle body and near the exit of the lumbar plexus nerve roots.
This study aims to follow up on the inital case series discussed above to evaluate the efficacy of the SPF block for post op analgesia in patients undergoing hemiarthroplasty surgery.
Aims and Objectives:
This will be a randomised control trial. The primary aim of this study is to further evaluate the efficacy of a sub-psoas muscle fascial plane regional block for providing adequate opioid-sparing/reducing post-operative analgesia, in comparrisson to patients who do not receive a regional anaesthesia block and standard analgesic regieme.
The secondary aim of this study is to explore patients' experience post-operatively in terms of their pain, time to remobilisation, total analgesic requirements, and quality of recovery.
Study End Points/Primary Objectives:
* To evaluate the post-operative analgesia provided by the proposed regional anaesthesia block, utilising:
* Quality of Recovery 15 (QoR15) Score
* Pain scores (Numerical rating scales, Pain Map, VAS, NRS)
* Intraoperative and Postoperative Opioid Requirements Quantification
* Time to remobilisation post-operatively
* (see supplementary material)
Study Design:
This trial will take place in the Anaesthetic and Orthopaedic Departments, University Hospital Galway. All participants will be treated with either the sub-psoas fascial plane block pre or post-operatively, or no regional anaesethesia with a standard analgesic regieme. written consent will be obtained from each participant. Where informed consent is attained, a clinical note review will take place in addition to the psoas muscle sympathetic chain block pre-operatively. Patients will be closely monitored throughout the procedure and surgery. They will be followed up in the post-anaesthetic care recovery unit to assess their pain, in addition to on day one and two on the ward where a full assessment of their recovery, pain, opioid requirements and overall post-operative course will be carried out by the anaesthetic team member involved in this study.
Study Methodology:
In this RCT, all patients enrolled will be undergoing either emergency hip surgery under the orthopaedic team in the theatre complex in University Hospital Galway. Ethical approval from the Galway Clinical Research Ethics Committee will be sought. Once approved, the procedure will be explained at length by the primary research or co-investigators to the patient and all questions will be addressed. The aim would be to provide a timeframe for the patient to consider the procedure before providing consent (i.e. during pre-operative assessment on the ward the night before or morning of their surgery and undergoing the consent process when in the theatre complex). If the patient is agreeable, verbal informed consent will be obtained. a clinical note review will take place to attain basic demographic and clinical data including diagnosis, indication for surgery, type of surgery, type of anaesthetic technique, comorbidities, preadmission opioid requirements. The procedure will be explained at length to the patient and if agreeable to proceed, the patient will be monitored closely as normally would occur in the theatre setting, they will be positioned in theatre briefly onto their lateral side. Under ultrasound-guidance the regional nerve block will be performed by the experienced consultant anaesthesiologist, whereby 30ml of 0.75% Ropivicaine will be slowly injected into the subpsoas fascial plane, whilst at all times throughout and following the procedures the patient will be closely haemodynamically monitored. The patient will be followed up in the recovery post-anaesthetic care unit up to four hours following their surgery. They will then be reviewed by the one of the co-investigators at a timeframe of 0-24 hours and 24-48 hours post-operatively to further establish their analgesic efficacy, their pain scores (see supplementary appendix), quality of recovery, time to remobilization and opioids requirements, ensuring the patient is comfortable and aiming to maximize their recovery period.
This is not a new technique, rather it is a new approach to a very well established and utilized technique - the psoas compartment block (PCB). The PCB utilizes a posterior approach whereby it traverses through the body of the psoas muscle thereby carrying the small risk profile of being near the plane of where the lumbar plexus roots exit the body of the muscle.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
SPF Block Group
In this RCT, all patients enrolled will be undergoing Emergency HemiArthroplasty in the theatre complex in University Hospital Galway.
Under ultrasound-guidance the SPF will be performed by the experienced consultant anaesthesiologist, whereby 30ml of 0.75% Ropivicaine will be slowly injected into the subpsoas fascial plane, whilst at all times throughout and following the procedures the patient will be closely haemodynamically monitored. The patient will be followed up in the recovery post-anaesthetic care unit up to four hours following their surgery. They will then be reviewed by the one of the co-investigators at a timeframe of 0-24 hours and 24-48 hours post-operatively to further establish their analgesic efficacy, their pain scores (see supplementary appendix), quality of recovery, time to remobilization and opioids requirements, ensuring the patient is comfortable and aiming to maximize their recovery period.
No interventions assigned to this group
No SPF Block Group
In this RCT, all patients enrolled will be undergoing Emergency HemiArthroplasty in the theatre complex in University Hospital Galway
Participants randomized to 'standard care' will receive the standard care required as determined by the treating team in the form of intravenous analgesia.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Individuals over 18 years of age.
* Individuals treated with psoas muscle sympathetic nerve blocks as part of multi-modal analgesic management.
* Individuals with the capacity to make an informed decision regarding study participation.
* Patients that provide written and verbal informed consent.
* Patients whom have not received a fascia iliacus block in the emergency department prior to their surgery.
Exclusion Criteria
* Individuals \< 18 years of age.
* Individuals with an intellectual disability (IQ \< 70), cognitive impairment, delirium or with dementia.
* Allergy to the local anaesthesia block components.
* Patients with absolute or relative contraindication to peripheral nerve blocks.
* Coagulopathy (Prothrombin time/International Normalized Ratio of more than 1.50, Activated Partial Thromboplastin Time of more than 60 seconds).
* Cases judged to be inappropriate by the chief investigator.
* Patients whom have received a fascia iliacus block in the emergency department prior to their surgery
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Prof John McDonnell
UNKNOWN
Prof John Laffey
UNKNOWN
University College Hospital Galway
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Orla Murphy
Dr Orla Murphy, Specialist Registrar Anaesthesia
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
C.A. 3190
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.